Literature DB >> 12961047

Routine magnetic resonance imaging of the spine in children with Gaucher disease: does it help therapeutic management?

Øystein E Olsen E1, Kieran McHugh, Ashok Vellodi.   

Abstract

BACKGROUND: Routine magnetic resonance imaging (MRI) surveillance of bone marrow change in patients with Gaucher disease (GD) is recommended, but interpretation of imaging findings in the developing skeleton may be difficult.
OBJECTIVES: To assess the agreement between routine spinal MRI findings and clinical course in paediatric GD patients receiving enzyme replacement therapy (ERT).
MATERIALS AND METHODS: A retrospective institutional review of all GD patients on ERT who had had repeated routine spinal MRI in accordance with national recommendations ( n=14) was carried out. Vertebral body bone marrow MRI T1 signal was assessed relative to intervertebral discs. MRI findings were then compared with recorded date(s) of ERT initiation and possible therapy changes.
RESULTS: Nine patients had spinal MRI both before and after the start of ERT. MRI T1 marrow signal was normal in two and abnormal in three of the nine patients both before and after the start of ERT. Two of the nine patients had normalization and one had conversion from normal to abnormal T1 signal. Interpretation was uncertain in one. Seven episodes of treatment intensification occurred. MRI T1 marrow signal was normal before five and uncertain before two of the seven episodes.
CONCLUSION: Routine spinal MRI had low accuracy for predicting clinically indicated therapy intensification.

Entities:  

Mesh:

Year:  2003        PMID: 12961047     DOI: 10.1007/s00247-003-1051-1

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  8 in total

1.  Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.

Authors:  C Hollak; M Maas; E Akkerman; A den Heeten; H Aerts
Journal:  Blood Cells Mol Dis       Date:  2001 Nov-Dec       Impact factor: 3.039

Review 2.  Clinically relevant therapeutic endpoints in type I Gaucher disease.

Authors:  C E Hollak; M Maas; J M Aerts
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

Review 3.  Imaging and quantifying skeletal involvement in Gaucher disease.

Authors:  M Maas; L W Poll; M R Terk
Journal:  Br J Radiol       Date:  2002       Impact factor: 3.039

4.  Pediatric spinal bone marrow: assessment of normal age-related changes in the MRI appearance.

Authors:  G H Sebag; J Dubois; M Tabet; A Bonato; D Lallemand
Journal:  Pediatr Radiol       Date:  1993

5.  Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results.

Authors:  L W Poll; J A Koch; S vom Dahl; R Willers; A Scherer; D Boerner; C Niederau; D Häussinger; U Mödder
Journal:  Skeletal Radiol       Date:  2001-09       Impact factor: 2.199

6.  Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.

Authors:  Mario Maas; Carla E M Hollak; Erik M Akkerman; Johannes M F G Aerts; Jaap Stoker; Gerard J Den Heeten
Journal:  AJR Am J Roentgenol       Date:  2002-10       Impact factor: 3.959

7.  Quantitative imaging of Gaucher disease.

Authors:  D I Rosenthal; N W Barton; K A McKusick; B R Rosen; S C Hill; F P Castronovo; R O Brady; S H Doppelt; H J Mankin
Journal:  Radiology       Date:  1992-12       Impact factor: 11.105

8.  Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.

Authors:  D I Rosenthal; S H Doppelt; H J Mankin; J M Dambrosia; R J Xavier; K A McKusick; B R Rosen; J Baker; L T Niklason; S C Hill
Journal:  Pediatrics       Date:  1995-10       Impact factor: 7.124

  8 in total
  1 in total

Review 1.  Gaucher disease: a systematic review and meta-analysis of bone complications and their response to treatment.

Authors:  Siavash Piran; Dominick Amato
Journal:  J Inherit Metab Dis       Date:  2010-03-25       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.